Scientific Program

Conference Series Ltd invites all the participants across the globe to attend International Conference and Expo on Cataract and Optometrists Meeting Manchester, UK.

Day 1 :

Keynote Forum

Randall J Olson

University of Utah John A Moran Eye Center, USA

Keynote: In vitro testing to show what actually does work to increase safety and efficiency in cataract surgery

Time : 09:35-10:10

Conference Series Cataract 2016 International Conference Keynote Speaker Randall J Olson photo

Randall J Olson, MD completed his BA in 1970 and his MD degree in 1973, both at the University of Utah. He completed his residency in Ophthalmology in 1977 at UCLA and then a fellowship in Cornea and External Diseases at the University of Florida and Louisiana State University School of Medicine in 1978, where he started his first faculty position. In 1979 he was recruited to the University of Utah to run a one person Division of Ophthalmology in the Department of Surgery. This has since grown to the present John A Moran Eye Center with 55 faculty members, over 500 employees and 210,000 square feet dedicated to clinical care, teaching and research. He serves as the CEO as well as the Department of Ophthalmology Chair. His key area of research is cataract surgery technology and complications. He lectures all over the world, has over 250 peer reviewed publications, and has been awarded the ASCRS Binkhorst medal in 2012 and the AAO Kelman medal in 2014.


While ultrasound based cataract removal through a small incision has been the standard form of cataract removal in the developed world for several decades, the technology available is constantly evolving with many claims of superiority made with little clinical evidence to back such claims. I will describe an approach that has allowed us to duplicate the removal of cataract segments with an in vitro model to finally determine what actually generates increased efficiency and suggest what may result in safety concerns at the same time. In a few short years we have published many peer reviewed articles using this technique. The published as well as our latest findings will be presented.

Keynote Forum

Iva Dekaris

University Eye Hospital ‘Svjetlost’, Croatia

Keynote: Refractive lens exchange with implantation of premium intraocular lenses

Time : 10:10-10:45

Conference Series Cataract 2016 International Conference Keynote Speaker Iva Dekaris  photo

Iva Dekaris is a Professor of Ophthalmology at Universities of Zagreb and Rijeka (Croatia), and Associate-member of the Department of Medical Sciences of the Croatian Academy of Sciences and Arts. She works as Medical Director at University Eye Hospital “Svjetlost” in Zagreb. Dr. Dekaris completed Postdoctoral Research Fellowship at Harvard Medical School and the Schepens Eye Research Institute in Boston. She was twice awarded with the highest Croatian State Reward for Achievements in Science (1999 and 2013). She is an immediate past president of the European Eye Bank Association (2010-2013).The areas of her expertise are corneal transplantation, cataract and refractive surgery. She has an overall experience of over 20,000 surgeries mainly PHACO, corneal transplantations, refractive lens exchange, phakic IOLs, amniotic membrane and stem-cell transplantations. She published 48 papers in CC Journals (citations: 393 Scopus), presented numerous invited talks all over the world, and co-authored 4 books.


Introduction: “Premium" intraocular lenses have advanced features beyond those found in basic mono-focal intraocular lenses (IOLs). Multifocal IOLs (m-IOLs), for example, are presbyopia-correcting lenses enabling almost spectacle-free life after conventional cataract surgery, or in case of refractive lens exchange (RLE). Currently, there is a whole spectrum of mIOLs on the market out of which bifocal IOLs correct only distance and near vision, while trifocal and extended range of vision IOLs provide also good intermediate vision. With invention of toric mIOLs, full visual correction may be obtained even in patients with pre-existing astigmatism. Our results with the implantation of different types of premium IOLs are presented.rnrnSubjects & Methods: In a period 2005-2015, at our Hospital over 3000 eyes had RLE with m-IOL implantation (Restor +4, Restor +3, Tecnis ZM900&ZMA00&ZMB00, Re-Zoom, Acry-Lisa & ATLISA 809MP, Tecnis Symfony and Trifocal ED). In last two years mostly trifocal and Symphony lenses were used, with the results presented in this study. Trifocal IOL: Ninety five patients (204 eyes) underwent bilateral trifocal IOL implantation (ATLISA tri839MP, Zeiss, Germany) after RLE. Patients were presbyopes; 95 hypermetropes and 7 myopes, aged 46 to 68 years. Twenty 20 eyes with hyperopic or myopic astigmatism received trifocal toric IOL (ATLISA tri-toric 939MP, Zeiss, Germany). Uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA) at 80 cm, uncorrected near visual acuity (UNVA), uncorrected distance visual acuity under 10% contrast level, visual disturbances and subjective satisfaction were measured and compared to Bifocal group (AT LISA 809MP; 42 patients, 84 eyes). Follow up was at least 6 months, up to three years. Symfony IOL: Forty six patients (92 eyes) were followed after RLE with bilateral implantation of the Tecnis Symfony IOL. Emmetropia was targeted in dominant eye, and mild myopia of up to -0.50 D in non-dominant eye. UDVA, UIVA at 66 cm, UNVA, spectacle independence, patient satisfaction and visual disturbances were measured. Follow up was at least 3 months. Results: Trifocal IOL: All patients achieved monocular UDVA better than 0.1 log-MAR, (76.9% of eyes 0.0 log-MAR). Monocular UIVA better than 0.2 log-MAR was achieved in 96.1% of patients. All patients could read J2 and better; 72.1% of patients could read J1. UDVA at 10% contrast level was 0.0 log-MAR in 62.5% of patients. Halo and glare were reported in 9.6% and 7.3% of cases, respectively. Spherical equivalent was equal or less than 0.5 D in 97% of trifocal eyes; and within the range of +1.00 to -1.00 D of astigmatism in all trifocal toric eyes. Symfony IOL: Binocular UDVA of 0.02 log-MAR or better was achieved in 95% of patients. Mean binocular UIVA at 66 cm was 0.01 log-MAR and UNVA at patient’s preferred distance was 0.01 log-MAR (J1-J2). Night driving visual disturbances was reported in 6 out of 46 patients (13%), only 2% of patients reported halos.rnrnConclusions: Refractive lens exchange with implantation of trifocal or Symfony IOL enables good vision at all distances and almost completes spectacle independence. It is an excellent choice for younger, active presbyopes in need of good intermediate vision. Meticulous preoperative counseling is of outmost importance to choose proper mIOL for each patient.rn